BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24459779)

  • 21. Knockoffs on the pharmacy shelf.
    Pasternak D
    US News World Rep; 2001 Jun; 130(23):26-7. PubMed ID: 11419218
    [No Abstract]   [Full Text] [Related]  

  • 22. Basics of compounding: repackaging, part 2.
    Allen LV
    Int J Pharm Compd; 2013; 17(2):136-40. PubMed ID: 23696175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
    Pritchett J; Mixon W; O'Connell K
    Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Battles over compounding from bulk drugs move forward.
    Clark A
    J Am Vet Med Assoc; 2005 Jul; 227(1):9-10. PubMed ID: 16013529
    [No Abstract]   [Full Text] [Related]  

  • 27. Compounding pharmacy: old methods finding a new niche.
    Matheny C; Martin CM
    Consult Pharm; 2010 Jun; 25(6):357-63. PubMed ID: 20534406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality planning, part 1: a holistic and practical approach.
    Odegard RD
    Int J Pharm Compd; 2013; 17(5):393-9. PubMed ID: 24459786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 30. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 31. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compounding in Ukraine.
    Zdoryk OA; Georgiyants VA; Gryzodub OI; Schnatz R
    Int J Pharm Compd; 2013; 17(2):124-7. PubMed ID: 23696172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial Identification in Pharmaceutical Compounding.
    Hyde T; Anstead J; Schade L; Zellner J
    Int J Pharm Compd; 2016; 20(1):13-8. PubMed ID: 27125052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GMPs vs GCPs: United States Pharmacopeia General Chapters.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
    [No Abstract]   [Full Text] [Related]  

  • 37. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thoughts on the improvement of the quality of the drugs prepared in the pharmacy].
    Hädicke M
    Pharm Prax; 1966 Apr; 4():103-4. PubMed ID: 6001079
    [No Abstract]   [Full Text] [Related]  

  • 39. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance.
    Greeson NM; Mixon W; Allan WC
    Int J Pharm Compd; 2020; 24(5):371-379. PubMed ID: 32886634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.